EMA Update: 25 Human Drugs at Risk of Brexit Supply Disruptions

The EMA lowered its estimate for the number of centrally authorized drugs that may face post-Brexit supply disruptions from 108 to 39 — including 25 human medicines.
Source: Drug Industry Daily